Likewise, Chen et al. [30] identified CCL3 as a promising biomarker of metastatic potential in pediatric medulloblastoma, highlighting its relevance in central nervous system tumors and further supporting its role in cancer progression. The gene discussed is CCL3; the disease is medulloblastoma.